Advisory Services Network’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Advisory Services Network’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,100	Closed	-$42K	–	3434
2021 Q2	$42K	Buy	+2,100	New	+$41.6K	﹤0.01%	2102
2021 Q1	–	Sell	-1,275	Closed	-$31K	–	3121
2020 Q4	$31K	Buy	1,275 +1,075	+538%	+$35.6K	﹤0.01%	1926
2020 Q3	$8K	Buy	+200	New	+$9.19K	﹤0.01%	2593
2019 Q1	–	Sell	-303	Closed	-$31K	–	2741
2018 Q4	$31K	Sell	303 -3,168	-91%	-$328K	﹤0.01%	1323
2018 Q3	$439K	Buy	+3,471	New	+$367K	0.03%	551

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.12B AUM 13.38% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's ICPT Position: Q3 2021 in Review

Advisory Services Network sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2021, closing a stake of 2,100 shares — an estimated $42K sold.

Advisory Services Network first reported a position in ICPT in Q3 2018 and held it in 5 quarters. The position peaked at $439K in Q3 2018. 139 funds tracked by Wall St. Rank hold ICPT as of Q3 2021.

Advisory Services Network reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 2,100 Intercept Pharmaceuticals, Inc. shares in Q3 2021, an estimated $42K.
Advisory Services Network first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
Advisory Services Network's Intercept Pharmaceuticals, Inc. position peaked at $439K in Q3 2018.
139 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.